Product Launch (Blog)

Nov, 17 2022

Self-Injections Market is Poised to Grow at 22.6% till 2024

According to Data Bridge Market Research new Market report "Global Self-Injections Market,By Type (Devices (Needle-Free, Auto, Pen, Wearable Injectors), Formulations), Dosage Form, Therapeutic Application, Route of Administration, End-User, Distribution Channel,Geography(North America, Europe, APAC, MEA, South America) - Trends and Forecast to 2024" is projected to reach USD 119.5 billion by 2024, from USD 23.4 billion in 2016 growing at the CAGR of 22.6 % in the forecast period 2017 to 2024.

Report Access: https://databridgemarketresearch.com/reports/global-self-injections-market-trends-forecast-2024/

In 2016, more than 65% of all drug developments globally are for biologic drug.The biosimilars market is expected to increase significantly with an approval pathway now available in the United States.Governments of Italy and France have noted that Avastin, a biologic developed for cancer, also treats macular degeneration.

The regulatory authorities in U.S., Europe among other geographies have mandated the prevention from needle stick injuries. Auto-injectors and needle free injectors have proved to be most effective to overcome these injuries with as much as 88% reductions. This is expected to surge the market for self-injections in the global market.The needle free self-injection devices segment is expected to grow owing to the increasing prevalence of needle phobia. According to CDC statistics in U.S. the phobia from needles have increased to 22.7% in 2015.

U.S. is striving to manage its healthcare costs and the realizations of self-injections may decrease the high costs of everyday in-patient and out-patient facilities. Also, the exponential growth of prefilled syringes will drive the market for self-injections to grow in the forecast years. In 2015, in Europe alone there was more than 2.4 billion units of pre-filled syringes shipped, which serves as an indicator for the growing needs of self-injection devices in the global market.

According to latest publication on Drug Delivery,In 2016 Injectable drug delivery devices market is expected to grow in future from 68.6 million to 142.0 million in 2026. Self-injection devices are expected to grow at a CAGR of 16.1%.

Market Segmentation: Self-Injections Market

  • The self-injections market is segmented based on type, dosage form, therapeutic application, route of administration, end-user, distribution channel, and geography.
  • On the basis of type, the global self-injections market is segmented into devices and formulations. The devices market is segmented into needle-free injectors, auto injectors, pen injectors, wearable injectors, and other devices.
  • The needle-free injectors market is further segmented on the basis of product, technology, and usability. The product segment is categorized into fillable and prefilled. The technology segment is further categorized into jet-based, spring-based, laser-powered, and vibration-based. The usability segment is further categorized into reusable and disposable.
  • Based on therapeutic application, the self injections market is segmented into autoimmune diseases, hormonal disorders, oncology, orphan diseases, pain management, respiratory therapy, and others. The market is also segmented based on dosage form into single dose and multi-dose.
  • On the basis of route of administration, the self injections market is segmented into skin, circulatory /musculoskeletal, organs, and central nervous system.
  • On the basis of end-user, the market is segmented into patient, physicians, home care settings and, others. The market is also segmented on the basis of distribution channel into hospital pharmacies, private clinics, chemist, and online pharmacies.

Geographical Segmentation: Self-Injections Market

Based on geography, the self-injections market is segmented into geographical regions such as North America, Europe, Asia-Pacific, South America, Middle East and Africa and, Rest of the World. The geographical regions are further segmented into 24 major countries such as U.S. Canada, Mexico, Germany, France, U.K., Belgium, Switzerland, Belgium, Turkey, Japan, China, Singapore, Brazil, India, Russia, South Africa and many others.

Competitive Landscape: Self-Injections Market

The global self-injections market report contains an in-depth profiling of the key market players, along with the recent developments (new product launches, partnerships, agreements, collaborations, and joint ventures) and strategies adopted by them to sustain and strengthen their positions in the market.Some examples of recent strategies adopted by market players are: December 2016, Mylan launched the first authorized generics for EpiPen Auto-Injector with the final retail cost of $300 per epinephrine injection (USP two-pack), which is less than 50% as compared to the retail cost of EpiPen 2-Pak Auto-Injectors.Also, in August 2016, PharmaJet announced a multi-year agreement with the World Health Organization to provide to PharmaJet needle-free technology to be used effort to eradicate polio. InMay 2014, Teva received the FDA approval for SYNRIBO (omacetaxinemepesuccinate) which is used in the treatment of adult patients in the chronic phase of chronic myeloid leukemia.

Some of the major players operating in this market are Abbvie, Inc., Antares Pharma, 3M,Becton Dickinson & Company, Baxter International Inc., Penjet Corporation, PharmaJet,GerresheimerAG,Pfizer Inc.,Terumo Corporation, Mylan N.V.,SHL Group,Bespak, Janssen Biotech Inc., Insulet Corporation, Unilife Corporation, West Pharmaceutical Services, Inc., Ypsomed, Eli lilly and Company,Haselmeier AG,Alkermes,AptarPharma,Credence MedSystems, Inc., SchottAG,Ypsomed, Owen Mumford Ltd., Glide Technologies,among other companies.

Browse Related Reports:

Global Topical Drug Delivery Market, By Product Type (Topical Drug Delivery Formulations (Solid, Liquid, Semi Solid), Transdermal Drug Delivery Devices (Transdermal Patches, Transdermal Gels)), By End-User (Hospitals, Clinics, Home Healthcare, Diagnostic Centers, Others), By Distribution Channel (Direct Tenders, Retail), By Geography (North America, Europe, Asia-Pacific, Latin America, Rest of the World) – Trends and Forecast to 2024.

https://databridgemarketresearch.com/reports/global-topical-drug-delivery-market-trends-forecast-2024/

Contact:

Data Bridge Market Research

Office Number 317, Amanora Chambers,

Magarpatta Road, Hadapsar

Pune – 411028

Maharashtra,India Toll Free: +1-888-387-2818

Email: Sales@databridgemarketresearch.com

Visit Data Bridge Blog@ https://www.databridgemarketresearch.com/blog/


CHOOSE LICENCE TYPE

  • 7000
  • 4800
  • 3000
  • 8000
  • 12000
Banner

Client Testimonials